Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 15, 2025
Silo Pharma Announces Pricing of $2 Million Public Offering
GlobeNewswire
·
May 15, 2025
SARASOTA, FL, May 15, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the pricing of a public …
Vaso Corporation Announces Financial Results for First Quarter of 2025
GlobeNewswire
·
May 15, 2025
PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and healthcare IT services, professional sales services, and proprietary medical products, …
LeanLaw Announces Strategic Integration with NetDocuments, Creating a Unified Legal Workflow for Law Firms
EIN Presswire
·
May 15, 2025
LeanLaw and NetDocuments join forces to unify billing and document workflows, eliminating inefficiencies and boosting productivity for modern law firms. BOISE, ID, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- LeanLaw, the premier legal billing …
High Grade at Globex’s Carp Fluorspar Property, Nevada
GlobeNewswire
·
May 15, 2025
ROUYN-NORANDA, Quebec, May 15, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …
Lipella Pharmaceuticals to Present Phase 2a Data for LP-310 in Oral Lichen Planus at 2025 AAOM/EAOM International Meeting
GlobeNewswire
·
May 15, 2025
Statistically significant safety and efficacy data from 0.25 mg and 0.50 mg cohorts to be presented Presentation scheduled for Thursday, May 15, 2025, at 11:36 a.m. PT PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) …
LOBO EV Technologies Ltd. Reaches $6 Million Agreement to Supply 5,000 Electric Vehicles to U.S. Market
GlobeNewswire
·
May 15, 2025
WUXI, China, May 15, 2025 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (NASDAQ: LOBO) ("LOBO" or the "Company"), an advanced manufacturer of electric bikes, tricycles, and off-highway four-wheeler electric carts, today reaffirmed its long-term commitment …
America’s Housing Affordability Gap Persists: Households Earning $75,000 Annually Can Afford Less Than a Quarter of For-Sale Home Listings
GlobeNewswire
·
May 15, 2025
WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- Key Highlights The U.S. housing market still needs 367,000 more home listings at a maximum price of $170,000, 416,000 more priced at or below $255,000 and 364,000 more priced under $340,000. For the U.S. housing …
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
GlobeNewswire
·
May 15, 2025
WARSAW, Poland, May 15, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …
Cemtrex Reports Second Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 15, 2025
Brooklyn, NY, May 15, 2025 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, has reported its financial and operational results for the fiscal second quarter ended March 31, 2024. Key …
SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
GRI Bio Reports First Quarter 2025 Financial Results and Confirms GRI-0621 Phase 2a IPF Trial on Track for 6-Week Interim Data in Q2 2025 and Topline Data in Q3 2025
GlobeNewswire
·
May 15, 2025
Positive interim 2-week safety and biomarker results from its ongoing Phase 2a study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (“IPF”) Continued momentum with completed patient enrollment for the 6-week interim analysis (n=24) …
Veri Medtech (VRHI) Reaches $100 Million Revenue Milestone
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (Stock Ticker Symbol: “VRHI”) ("Veri Medtech"), healthcare technology platform, announced today that $3,308,297 in revenue was generated during the first quarter of 2025, with an …
Smart Automation is Transforming Small-scale Poultry Farming, Driving the Next Wave of Poultry Keeping Machinery Market
EIN Presswire
·
May 15, 2025
Smart automation is transforming small-scale poultry farming, unlocking growth in the poultry machinery market with cost-effective, tech-enabled solutions. NEWARK, DE, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- The global poultry keeping …
Wake-up call for business leaders: Just 10% of deskless workers are happy with quality of workplace communication
GlobeNewswire
·
May 15, 2025
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Staffbase, the leading employee communications cloud platform, today announced the results of its 2025 Employee Communication Impact Study during the VOICES 2025 virtual event. The report examines the employee …
Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 15, 2025
GLEN ALLEN, Va., May 15, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
CorMedix Inc. to Participate in the RBC Global Healthcare Conference
GlobeNewswire
·
May 15, 2025
BERKELEY HEIGHTS, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the RBC …
HeartCore Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 15, 2025
NEW YORK and TOKYO, May 15, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the first quarter …
DTST Reports 2025 First Quarter Financial Results and Provides Business Update
GlobeNewswire
·
May 15, 2025
Strong Q1 2025 Performance Driven by 14% YoY Revenue Growth in Cloud Infrastructure and Disaster Recovery Services CloudFirst International Expansion Accelerated Through Strategic Partnership with Pulsant Conference Call to be held today at 11:00 am ET …
Akari Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
Advancing development of novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads to treat multiple cancer tumors Rounding out executive team with deep oncology experience by appointing new Head of Business Development - Oncology BOSTON and …
Retrospective Analysis of U.S. Claims Data Shows AUVI-Q® (epinephrine injection, USP) Prescription Associated with Lower Rates of Anaphylaxis-Related Inpatient Hospitalizations Compared to Other Epinephrine Auto-Injectors
GlobeNewswire
·
May 15, 2025
Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q® (epinephrine injection, USP) experienced lower rates of inpatient hospitalization for …